Viva Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Viva-APAC

More Like This

PR Newswire associated0

Viva Biotech Launches the AI-Driven Drug Discovery Platform, Transforming New Drug R&D Logic, Enabling One-Stop Innovative Drug Discovery

PR Newswire associated0

Viva Biotech Accelerates AI-Driven Drug Discovery and Advance the 'Lab-in-the-Loop' with NVIDIA

PR Newswire associated0

Fifteen Years Alongside Europe's Drug Discovery Teams: Viva Biotech Strengthens Continuity from Discovery to Development and Manufacturing

PR Newswire associated0

Viva Biotech Announces 2025 Annual Results: AI-Driven Drug Discovery Reinforces Industry Leadership, CDMO Commercial Products Enter Rapid Scale-Up

Viva Biotech Officially Establishes Boston Branch, Marking Another Milestone in Global Expansion

PR Newswire associated0

Adventures in DMPK: Viva Biotech's One-Stop Pharmacology Platform Cross New Modalities

PR Newswire associated0

Viva Biotech's invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion.

Avance Clinical Wins 2024 Frost & Sullivan Award for Global Biotech CRO Excellence